Thursday, 13 Dec 2018

You are here

Hip Replacement Augments Longevity

Data from Swedish hip replacement registry finds that total hip arthroplasty (THA) not only improves quality of life, it is also associated with increased life expectancy that lasts at least 0 years after surgery, especially in primary osteoarthritis (OA) patients. (Citation source: https://buff.ly/2CQW0cC)

Researchers studied the survival rate of 131,808 patients undergoing THA from 1999-2012.  There were 21,755 deaths (16.5%) with a median follow-up of 5.6 years.

After one year, survival was one percent better in THA patients and 3% by five years. By 12 years, survival was no longer different for THA patients compared to the general population.

The survival difference was significant mainly among patients diagnosed with primary osteoarthritis.

Increasing comorbidities, lower education and being single led to lower survival after THA. Poorer relative survival was seen with THA done for osteonecrosis of the femoral head, inflammatory arthritis and secondary osteoarthritis. 

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Dendrimer Nanocarrier Delivers IGF-1 to Degenerative Cartilage

Researchers from MIT have developed a novel treatment for osteoarthritis (OA) by using dendrimer-based nanocarriers to deliver insulin-like growth factor 1 (IGF-1) to chondrocytes within joint cartilage and in animal models have shown when these nanocarriers injected into rat knees in models of OA, they reduced cartilage degeneration.

Low Risk of Serious Complications with Meniscectomy

Lancet reports on the safety of over 1 million arthroscopic partial meniscectomies done in the United Kingdom and found a low overall risk in the first 90 days. They examined Hospital Episode Statistics on  1,088,782 arthroscopic partial meniscectomies (1997-2017); 699 965 of which were eligible for analysis. They sought to identify complications occurring in the 90 days after the index procedure.

Pre-Diabetes Associated Risk for Arthritis, Obesity and Physical Inactivity

The current MMWR reports that arthritis is seen in nearly one-third of adults with prediabetes and that more than half of such patients are obese and not engaged in regular physical activity.

Doctor-diagnosed arthritis affects 54.4 million in the U.S. and the CDC expects this to rise to 78.4 million by 2040.

Controversial New Super Opioid Approved by FDA

Amidst a new DEA report demonstrating a record number of opioid overdose deaths (n-72,000 or ~ 200 deaths per day), the FDA has approved a newer and far more potent opioid than those that are currently being abused at alarming rates. The new agent is named Dsuvia.

Late Breaker: Can Tanezumab Be Revived for OA?

The monoclonal antibody tanezumab, which blocks nerve growth factor, showed significant benefits in pain and function among patients with osteoarthritis (OA) of the knee or hip, and rates of severe adverse joint events such as rapidly progressive OA that had plagued earlier studies were low, a researcher reported at the annual meeting of the American College of Rheumatology in Chicago last week.